Meetings

  • This meeting is open to BPNS members and other professionals working in relevant areas, but not to patients or members of the general public without advance permission.
Spring 2024 Meeting: VIRTUAL
Start Date
End Date
Friday 22 Mar 2024 10:00 AM
Friday 22 Mar 2024 17:00 PM
Location
The Liverpool Medical Institution
Details

Our usual mix of case presentations (neurology/neurophysiology) and invited lectures is of interest to trainees/consultants and nerve specialists/non-specialists alike.  This years meeting follows our 2-yearly Teaching Course the preceding day, which may also be of interest.  Both meetings will be at the historic Liverpool Medical Institute, located in the heart of Liverpool and a short walk from the Anglican and Catholic cathedrals.  The meeting is in person or virtual via Zoom, with pricing the same for both to reflect rising AV costs and encourage in-person attendance.  There will be a dinner after the meeting which is booked separately on the website (dinner listed as a separate meeting).

PAYMENT INFORMATION

Cost for associate members is £50, for ordinary members £70, and for non-members £90 for the meeting registration (lunch and refreshments included).  Due to PayPal changes, our payment system through the website doesn't work, so instead register through the website 'for free' and then pay separately through PayPal, either by searching for Aisling.Carr@nhs.net through PayPal or more simply by typing PayPal.me/bpns22 into your web browser: you will then be asked to log in or sign up to PayPal before being asked to set the amount to pay Aisling Carr, our treasurer.  If you do not have a PayPal account and do not wish to sign up, you can email aisling.carr@nhs.net to agree another option.

Programme (can change before the event)
DateTimeType Presenter
Fri 22 Mar 202409:30Registration All sponsors of this meeting have no input into the organization or agenda; our sponsors are: CompanyA, CompanyB, CompanyC  
Fri 22 Mar 202410:00Other See under IN-PERSON meeting for full program  

Latest News

Queen Square Annual Update in Neuromuscular Disorders

 This course will be held from Tuesday 7th to Thursday 9th May in the Clinical Neuroscience Lecture Theatre, Lower ground, 33 Queen Square, London WC1N 3B

 REGISTRATION  (right click and select - open in new window or open in new tab)     

 PROGRAMME

Brain Fellowships

Applications are invited for 1 year fellowships funded by the Guarantors of Brain. These fellowships provide bridging salary support  to early career clinicians based in the UK prior to obtaining a research fellowship. Further details can be found HERE

Hereditary Neuropathy Serine Trial

The Hereditary Sensory Neuropathy Serine trial (SENSE trial)  ClinicalTrials.gov Identifier:        NCT06113055

The Hereditary Sensory Neuropathy Serine trial (SENSE trial) is open to recruitment.  This is a randomised double-blind placebo-controlled trial of L-serine in Hereditary Sensory Neuropathy type 1 (HSN1) due to variants in SPTLC1/2 gene.

 This is a single-centre study being conducted at the National Hospital for Neurology and Neurosurgery, London UK. The Chief Investigator for this trial is Professor Mary M Reilly.  If you have any affected patients who you think may interested in taking part then please invite them to contact the trial team for further information.

Recruitment will close August 2024.

New UK Charity for Peripheral Neuropathy

The BPNS wish to facilitate setup of a new charity for peripheral neuropathy in the UK.  There is no charity or association in the UK which supports people with all the many causes of peripheral neuropathy.  Only a few specific causes of neuropathy have a UK charity, such as CMT-UK, GAIN and Diabetes UK.  There is no UK charity to support idiopathic neuropathy, painful small fibre neuropathy (except general pain charities), brachial neuritis, carpal tunnel and entrapment neuropathies, chemotherapy neuropathy (except cancer charities), etc. Several people have come forward to assist with this and work is progressing to get the new charity up and running.

More news »